Analysts' ratings for Oracle ORCL over the last quarter vary from bullish to bearish, as provided by 19 analysts.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 4 | 6 | 9 | 0 | 0 |
| Last 30D | 0 | 0 | 0 | 0 | 0 |
| 1M Ago | 0 | 1 | 0 | 0 | 0 |
| 2M Ago | 4 | 5 | 9 | 0 | 0 |
| 3M Ago | 0 | 0 | 0 | 0 | 0 |
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $137.47, with a high estimate of $160.00 and a low estimate of $105.00. Marking an increase of 10.08%, the current average surpasses the previous average price target of $124.88.
Deciphering Analyst Ratings: An In-Depth Analysis
A comprehensive examination of how financial experts perceive Oracle is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Jason Ader | Keybanc | Announces | Overweight | $150.00 | - |
| Kash Rangan | Goldman Sachs | Raises | Neutral | $130.00 | $115.00 |
| Stephen Bersey | HSBC | Raises | Buy | $155.00 | $144.00 |
| Kirk Materne | Evercore ISI Group | Raises | Outperform | $145.00 | $130.00 |
| Derrick Wood | TD Cowen | Raises | Outperform | $145.00 | $130.00 |
| Keith Bachman | BMO Capital | Raises | Market Perform | $142.00 | $126.00 |
| Kash Rangan | Goldman Sachs | Raises | Neutral | $130.00 | $115.00 |
| Siti Panigrahi | Mizuho | Raises | Buy | $160.00 | $140.00 |
| Brent Bracelin | Piper Sandler | Raises | Overweight | $140.00 | $122.00 |
| Brad Reback | Stifel | Raises | Hold | $120.00 | $100.00 |
| Gil Luria | DA Davidson | Announces | Neutral | $105.00 | - |
| Karl Keirstead | UBS | Raises | Buy | $150.00 | $130.00 |
| Keith Weiss | Morgan Stanley | Raises | Equal-Weight | $115.00 | $106.00 |
| Mark Moerdler | Bernstein | Raises | Outperform | $159.00 | $147.00 |
| Brad Sills | B of A Securities | Raises | Neutral | $144.00 | $122.00 |
| Brent Thill | Jefferies | Raises | Buy | $150.00 | $145.00 |
| Mark Murphy | JP Morgan | Raises | Neutral | $105.00 | $100.00 |
| Raimo Lenschow | Barclays | Raises | Overweight | $147.00 | $140.00 |
| Tyler Radke | Citigroup | Raises | Neutral | $120.00 | $111.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Oracle. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Oracle compared to the broader market.
- Price Targets: Gaining insights, analysts provide estimates for the future value of Oracle's stock. This comparison reveals trends in analysts' expectations over time.
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of Oracle's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
Stay up to date on Oracle analyst ratings.
Delving into Oracle's Background
Oracle provides database technology and enterprise resource planning, or ERP, software to enterprises around the world. Founded in 1977, Oracle pioneered the first commercial SQL-based relational database management system. Today, Oracle has 430,000 customers in 175 countries, supported by its base of 136,000 employees.
Oracle: Financial Performance Dissected
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Over the 3 months period, Oracle showcased positive performance, achieving a revenue growth rate of 7.11% as of 29 February, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Oracle's net margin excels beyond industry benchmarks, reaching 18.08%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Oracle's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 50.61% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Oracle's ROA stands out, surpassing industry averages. With an impressive ROA of 1.77%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Oracle's debt-to-equity ratio surpasses industry norms, standing at 15.65. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
The Core of Analyst Ratings: What Every Investor Should Know
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
